Ouafki Imane, Nouiakh Lamyae, Boujarnija Raihana, Amarti Afaf, Amaadour Lamiae, Oualla Karima, Benbrahim Zineb, Arifi Samia, Mellas Nawfel
Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.
Centre d´Anatomo-pathologie Al Azhar, Fès, Maroc.
Pan Afr Med J. 2021 Jan 27;38:92. doi: 10.11604/pamj.2021.38.92.24462. eCollection 2021.
Primary malignant mesothelioma of the ovary (PMMO) is an extremely rare tumor which can develop from mesothelial cells. This neoplasia is caused predominantly by exposure to asbestos or other cancer-causing agents. Preoperative assessment, based on computed tomography (CT) scan, magnetic resonance imaging and positron emission tomography, is essential for cancer staging. Anatomopathological diagnosis is based on immunohistochemical findings. PMMO is an exceptional disease involving a multidisciplinary therapeutic strategy including the use of chemotherapy which improves the management and prognosis of patients. This study reports the case of a female patient undergoing suboptimal surgery complemented by adjuvant chemotherapy with complete radiological response and 1-year disease-free survival.
原发性卵巢恶性间皮瘤(PMMO)是一种极为罕见的可由间皮细胞发展而来的肿瘤。这种肿瘤主要由接触石棉或其他致癌物质引起。基于计算机断层扫描(CT)、磁共振成像和正电子发射断层扫描的术前评估对于癌症分期至关重要。解剖病理学诊断基于免疫组化结果。PMMO是一种特殊疾病,需要多学科治疗策略,包括使用化疗,这有助于改善患者的治疗和预后。本研究报告了一例女性患者,接受了不太理想的手术,并辅以辅助化疗,取得了完全的影像学反应和1年无病生存期。